What it addresses
The skin beneath the eye is four times thinner than the rest of the face. GHK-Cu targets dermal thinning in the periorbital area by stimulating collagen in fibroblasts — as dermal density increases, vascular structures below become less visible. Caffeine addresses microcirculation and transient puffiness.
Protocol details
Format6 mini dual-chamber vials
CompoundGHK-Cu + Caffeine
ConcernEye · Awakening
TierRegenerative
CadenceRestoration Cycle
ActivationMix at point of use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.